HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation.

Abstract
Cell migration is a prerequisite for cancer invasion and metastasis, suggesting cell motility as a potential therapeutic target for cancer treatment. A synthetic library was screened to identify inhibitors of tumor cell migration. From this, we discovered that CAC-1098 (aurintricarboxylic acid) and CBI-0997 (5-(2,4-dimethoxy-5-ethylphenyl)-4-(4-bromophenyl) isoxazole) inhibited migration of MDA-MB-231 cells with IC50 = 5 and 50 nM, respectively. We synthesized KRIBB3 (5-(5-ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-methoxyphenyl) isoxazole) by replacing the bromide group of CBI-0997 with a methoxyl group. Like CBI-0997, KRIBB3 has anti-migratory and anti-invasive activities in MDA-MB-231 cells. Because KRIBB3 has a better drug-like structure, we focused our effort on further understanding its anti-migratory mechanism. Biotinyl-KRIBB3 was synthesized as an affinity probe for identification of KRIBB3-binding proteins. Using affinity chromatography, we identified Hsp27 as a target protein of KRIBB3 in vitro. Treatment of MDA-MB-231 cells with phorbol 12-myristate 13-acetate induced protein kinase C-dependent phosphorylation of Hsp27 and tumor cell migration. In contrast, treatment of MDA-MB-231 cells with KRIBB3 blocked phorbol 12-myristate 13-acetate-induced phosphorylation of Hsp27 and tumor cell migration. Furthermore, overexpression of Hsp27 antagonized the inhibitory effect of KRIBB3 on tumor cell invasion, and knockdown of Hsp27 using small interfering RNA inhibited tumor cell migration. Overall, our results demonstrate that KRIBB3 inhibits tumor cell migration and invasion by blocking protein kinase C-dependent phosphorylation of Hsp27 through its direct binding to Hsp27.
AuthorsKi Deok Shin, Mi-Young Lee, Dae-Seop Shin, Sangku Lee, Kwang-Hee Son, Sukhoon Koh, Young-Ki Paik, Byoung-Mog Kwon, Dong Cho Han
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 280 Issue 50 Pg. 41439-48 (Dec 16 2005) ISSN: 0021-9258 [Print] United States
PMID16234246 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 5-(5-ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-methoxyphenyl)isoxazole
  • Anisoles
  • Antineoplastic Agents
  • Bromides
  • Crk-Associated Substrate Protein
  • DNA, Complementary
  • Enzyme Inhibitors
  • HSP27 Heat-Shock Proteins
  • HSPB1 protein, human
  • Heat-Shock Proteins
  • Intracellular Signaling Peptides and Proteins
  • Isoxazoles
  • Molecular Chaperones
  • Neoplasm Proteins
  • RNA, Small Interfering
  • MAP-kinase-activated kinase 2
  • Focal Adhesion Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Protein Kinase C
Topics
  • Amino Acid Sequence
  • Anisoles (chemistry, pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Blotting, Western
  • Bromides (chemistry)
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Cell Movement
  • Chromatography, Affinity
  • Crk-Associated Substrate Protein (metabolism)
  • DNA, Complementary (metabolism)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Focal Adhesion Protein-Tyrosine Kinases (metabolism)
  • HSP27 Heat-Shock Proteins
  • Heat-Shock Proteins (antagonists & inhibitors)
  • Humans
  • Inhibitory Concentration 50
  • Intracellular Signaling Peptides and Proteins
  • Isoxazoles (chemistry, pharmacology)
  • Models, Chemical
  • Molecular Chaperones
  • Molecular Sequence Data
  • Neoplasm Invasiveness
  • Neoplasm Proteins (antagonists & inhibitors)
  • Neoplasms (drug therapy, metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Protein Binding
  • Protein Kinase C (metabolism)
  • Protein Serine-Threonine Kinases (metabolism)
  • Protein Structure, Tertiary
  • RNA, Small Interfering (chemistry, metabolism)
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: